Poland· PL-100388372
Pergoveris
A gonadotropine, kombinationen product containing lutropinum alfa + folitropinum alfa, registered in Poland by Merck Europe B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Gonadotropine, kombinationen is registered in 11 of 19 countries.
Countries holding a registration under ATC G03GA30 (gonadotropine, kombinationen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Gonadotropine, kombinationen · ATC G03GA30
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Lutropinum alfa + Folitropinum alfa
- Manufacturer
- Merck Europe B.V.
- Country
- Poland (PL)
- ATC code
- G03GA30
- ATC class
- Gonadotropine, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin04054839340123
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Gonadotropine, kombinationen in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainPERGOVERIS (300 UI + 150 UI)/0,48 ML SOLUCION INYECTABLE EN PLUMA PRECARGADAMerck Europe B.V.
- FinlandPergoverisMerck Europe B.V.
- CzechiaPERGOVERISMerck Europe B.V., Amsterdam
- United KingdomPergoveris 150unit/75unit powder and solvent for solution for injection vialsMerck Serono Ltd
- IrelandPergoveris (300 IU + 150 IU)/0.48 mL solution for injection in pre-filled penMerck Europe B.V.
- IcelandPergoverisMerck Europe B.V.*
- CanadaPERGOVERISEMD SERONO, A DIVISION OF EMD INC., CANADA
- SwitzerlandPergoveris Pen 300 IE/150 IE/0.48 ml, Injektionslösung im FertigpenMerck (Schweiz) AG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Pergoveris
- Liechtenstein · Pergoveris
- Norway · Pergoveris
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/752615bc-acd6-41fe-82fc-af82a2e7a981 GET /v1/drugs/752615bc-acd6-41fe-82fc-af82a2e7a981?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "(900 j.m. + 450 j.m.)/1,44 ml",
"packaging": "04054839340123 ¦ Rpz ¦ EU/1/07/396/006 ¦ 122705\n1 wstrzykiwacz 1,44 ml + 14 igieł",
"substance": "Lutropinum alfa 900 j.m./1.44 ml + Folitropinum alfa 450 j.m./1.44 ml",
"common_name": "Lutropinum alfa + Folitropinum alfa",
"pl_product_id": "100388372",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about gonadotropine, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.